Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product
Titel:
Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product
Auteur:
Niederwieser, Dietger Hamm, Caroline Cobb, Patrick Mo, Mindy Forsyth, Cecily Tucci, Alessandra Hanes, Vladimir Delwail, Vincent Hajek, Roman Chien, David